Top Markets
Coin of the day
Genomma Lab Internacional, S.A.B. de C.V. Genomma Lab Internacional, S.A.B. de C.V.

Genomma Lab Internacional, S.A.B. de C.V.

LABB
Rangering i aksjer #10943
Genomma Lab Internacional, S.A.B. de C.V., along with its subsidiary companies,... Genomma Lab Internacional, S.A.B. de C.V., along with its subsidiary companies, specializes in the formulation, promotion, and worldwide distribution of non-prescription pharmaceuticals and personal hygiene products. The firm's extensive product range covers areas such as skincare, general health and wellness, haircare, pain management, cold and flu remedies, gastrointestinal treatments, sexual health, antiperspirant deodorants, hand sanitizers, rehydration drinks, and shaving essentials. It also provides analgesics, antifungal solutions, and hemorrhoid treatments. These items are sold under numerous recognized brands, including Cicatricure, Asepxia, Teatrical, Goicoechea, Sistema GB, Medicasp, Tío Nacho, Vanart, Novamil, Ultra Bengue, X-Ray, Tafirol, Alliviax, Bufferin, Next, XL-3, Genoprazol, QG5, Kaopectate, Proctan, Nikzon, Unesia, Silka Medic, lagicam, Suerox, Groomen, DiabetTX, among others. Incorporated in 1996, Genomma Lab Internacional, S.A.B. de C.V. is headquartered in Mexico City, Mexico.
Aksjekurs
$0.78199085
Sist synkronisert: 2026-08-28
Markedsverdi
$764.59M
Endring (1 dag)
-0.30%
Endring (1 år)
-34.64%
Land
MX
Handel Genomma Lab Internacional, S.A.B. de C.V. (LABB)

Kategori

P/B-forhold for Genomma Lab Internacional, S.A.B. de C.V. (LABB)
P/B-forhold per 2026 TTM: 0
Ifølge Genomma Lab Internacional, S.A.B. de C.V. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Genomma Lab Internacional, S.A.B. de C.V. fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter